Skip to main content
Guidance

Epidemiological case definitions for severe fever with thrombocytopaenia syndrome (SFTS) in the UK

Epidemiological case definitions for SFTS.

Who this guidance is for

Guidance for healthcare professionals on when to suspect severe fever with thrombocytopenia syndrome (SFTS) is available and should be used as the starting point for clinical assessment of a suspected case of SFTS.

This guidance describes the epidemiological case definitions of possible, probable and confirmed cases of SFTS for use during contact tracing once a case has been identified in the UK. 

In this guidance, ‘body fluids’ includes blood, vomit, faeces, urine, saliva and semen.

For personal protective equipment (PPE) requirements for the management of SFTS cases, please see the ACDP Guidance on the Management of Patients with Viral Haemorrhagic Fever.  

Any individual who has not had contact with a potential source of SFTS virus, for example a probable or confirmed case of SFTS or their body fluids, within the last 14 days before onset of illness is highly unlikely to be at risk of SFTS.

Case definitions

Confirmed case

An individual (alive or deceased) with a positive laboratory test result (real-time polymerase chain reaction (PCR)) from blood or other body fluid sample.

Probable case

An individual for whom no laboratory results are available (for example waiting for testing or results) where both of the following apply:

  1. Clinical illness compatible with SFTS [note 1] characterised by fever (temperature greater than 37.5 C) or symptoms such as severe weakness, severe headache, myalgia, abdominal pain, vomiting, diarrhoea or unexplained haemorrhage.
  2. History of direct contact with a probable or confirmed case of SFTS, or their body fluids, including for laboratory staff, during the 14 days before the onset of symptoms, without appropriate PPE or where there were breaches in PPE.

Possible case

A deceased individual, with no diagnosed cause of death, with epidemiological risk factors for SFTS [note 2]

or:

An individual for whom no laboratory results are available (for example waiting for testing or results), where both the following apply:

  1. Clinical illness compatible with SFTS [note 1], comprising of fever (temperature greater than 37.5°C) or symptoms such as severe weakness, severe headache, myalgia, abdominal pain, vomiting, diarrhoea or unexplained haemorrhage.
  2. History of direct contact with a confirmed case of SFTS or their body fluids (including laboratory staff) in the 14 days before the onset of symptoms, but wore appropriate PPE with no known breaches.

Note 1: initial symptoms may be not specific, but onset can be sudden with symptoms worsening over a few days, often with lethargy, rash and evidence of capillary leak.

Note 2: deceased individuals with an epidemiological link to the outbreak should be discussed with the Imported Fever Service (IFS) for consideration of post-mortem testing.

Sign up for emails or print this page